You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指升263點; 恆生科技指數升84點 騰訊升逾3% 網易、賽生藥業、海通國際創新高
恆指半日收17,717點,升263點或1.5%。恆生科技指數報4,065點,升84點或2.1%。國指升107點或1.8%,報6,081點。 活躍重磅股表現: 騰訊(00700.HK) 收327.6元,上升3.9%; 建行(00939.HK) 收4.6元,上升1.5%; 阿里巴巴(09988.HK) 收74.2元,上升1.3%; 美團(03690.HK) 收107.9元,上升0.6%; 友邦(01299.HK) 收72.85元,下跌0.1%; 異動恆指及國指成份股: 中信股份(00267.HK) 收7.42元,上升5.5%; 信義光能(00968.HK) 收5.22元,上升4.8%; 海底撈(06862.HK) 收16.82元,上升4.3%; 商湯-W(00020.HK) 收1.54元,上升4.1%; 京東集團(09618.HK) 收109.5元,上升3.9%; 國藥(01099.HK) 收19.4元,上升3.7%; 京東健康(06618.HK) 收39.25元,上升3.7%; 小鵬汽車(09868.HK) 收67.55元,上升3.7%; 蒙牛(02319.HK) 收25.4元,上升3.7%; 百威亞太(01876.HK) 收15.76元,上升3.5%; 中升控股(00881.HK) 收19.94元,上升3.5%; 新奧能源(02688.HK) 收58.25元,上升3.3%; 中芯(00981.HK) 收22.3元,上升3.2%; 網易(09999.HK) 收185.1元,上升3.2%,創新高; 異動綜合中小型股: 醫思健康(02138.HK) 收2.11元,下跌12.8%; 開拓藥業-B(09939.HK) 收3.31元,上升12.2%; 來凱醫藥-B(02105.HK) 收25元,上升10.4%; 賽生藥業(06600.HK) 收12.44元,上升5.2%,創新高; 海通國際(00665.HK) 收1.48元,無升跌,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account